Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
Status:
Withdrawn
Trial end date:
2019-05-01
Target enrollment:
Participant gender:
Summary
Adenomyosis affects approximately 21% of symptomatic women who present to gynecology clinics.
The disease is characterized by heavy bleeding and pain during periods. Limited treatment
options exist for the treatment of adenomyosis for women who desire future child-bearing or
prefer to avoid surgery. Recently, ulipristal acetate has been studied as a treatment option
for women who have fibroids and heavy bleeding. The majority of women treated with ulipristal
stopped having periods altogether. Our study aims to determine whether ulipristal is an
adequate treatment for women with adenomyosis.